Compare SMCI & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SMCI | BNTX |
|---|---|---|
| Founded | 1993 | 2008 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Computer Manufacturing | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.1B | 22.8B |
| IPO Year | 2006 | 2019 |
| Metric | SMCI | BNTX |
|---|---|---|
| Price | $20.47 | $89.17 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 16 | 13 |
| Target Price | $39.53 | ★ $134.15 |
| AVG Volume (30 Days) | ★ 19.3M | 1.2M |
| Earning Date | 05-05-2026 | 03-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.86 | N/A |
| Revenue | ★ $2,484,929,000.00 | N/A |
| Revenue This Year | $90.56 | N/A |
| Revenue Next Year | $19.83 | $4.76 |
| P/E Ratio | $35.74 | ★ N/A |
| Revenue Growth | ★ 11.68 | N/A |
| 52 Week Low | $27.61 | $79.81 |
| 52 Week High | $62.36 | $124.00 |
| Indicator | SMCI | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 23.23 | 36.41 |
| Support Level | N/A | $79.81 |
| Resistance Level | $33.60 | $112.30 |
| Average True Range (ATR) | 1.51 | 3.52 |
| MACD | -0.79 | -0.83 |
| Stochastic Oscillator | 0.87 | 38.50 |
Super Micro Computer Inc provides high-performance server technology services to cloud computing, data centers, high-performance computing, and the Internet of Things embedded markets. Its solutions include servers, storage systems, modular blade servers, workstations, full-rack scale solutions, networking devices, server sub-systems, and server management. These turn-key solutions are designed, developed, validated, and installed for AI datacenters. The company has one operating segment that develops and provides high-performance server solutions based upon a, modular and open-standard architecture. More than half of the firm's revenue is generated in the United States, with the rest coming from Europe, Asia, and other regions.
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.